The Predictive Ability of 4MGS in IPF

CompletedOBSERVATIONAL

Enrollment

132

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 20, 2017

Study Completion Date

October 20, 2017

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

OTHER

4MGS

Usual walking speed measured over 4 metres

Trial Locations (1)

Royal Brompton and Harefield NHS Foundation Trust, Harefield

All Listed Sponsors

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Royal Brompton & Harefield NHS Foundation Trust

OTHER

NCT02436278 - The Predictive Ability of 4MGS in IPF | Biotech Hunter | Biotech Hunter